- Home
- CMPS vs PBPB Comparison
CMPS vs PBPB Comparison
Compare CMPS & PBPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- PBPB
- Stock Information
- Founded
- CMPS 2020
- PBPB 1977
- Country
- CMPS United Kingdom
- PBPB United States
- Employees
- CMPS N/A
- PBPB N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- PBPB Restaurants
- Sector
- CMPS Health Care
- PBPB Consumer Discretionary
- Exchange
- CMPS Nasdaq
- PBPB Nasdaq
- Market Cap
- CMPS 322.5M
- PBPB 278.1M
- IPO Year
- CMPS 2020
- PBPB 2013
- Fundamental
- Price
- CMPS $2.79
- PBPB $9.81
- Analyst Decision
- CMPS Strong Buy
- PBPB Strong Buy
- Analyst Count
- CMPS 7
- PBPB 3
- Target Price
- CMPS $21.83
- PBPB $15.33
- AVG Volume (30 Days)
- CMPS 1.0M
- PBPB 348.8K
- Earning Date
- CMPS 05-07-2025
- PBPB 03-06-2025
- Dividend Yield
- CMPS N/A
- PBPB N/A
- EPS Growth
- CMPS N/A
- PBPB 670.59
- EPS
- CMPS N/A
- PBPB 1.31
- Revenue
- CMPS N/A
- PBPB $462,598,000.00
- Revenue This Year
- CMPS N/A
- PBPB $5.67
- Revenue Next Year
- CMPS N/A
- PBPB $3.78
- P/E Ratio
- CMPS N/A
- PBPB $7.26
- Revenue Growth
- CMPS N/A
- PBPB N/A
- 52 Week Low
- CMPS $2.69
- PBPB $6.28
- 52 Week High
- CMPS $10.31
- PBPB $13.48
- Technical
- Relative Strength Index (RSI)
- CMPS 31.50
- PBPB 45.11
- Support Level
- CMPS $2.88
- PBPB $9.16
- Resistance Level
- CMPS $3.16
- PBPB $9.68
- Average True Range (ATR)
- CMPS 0.21
- PBPB 0.42
- MACD
- CMPS -0.03
- PBPB 0.09
- Stochastic Oscillator
- CMPS 9.30
- PBPB 91.09
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About PBPB Potbelly Corporation
Potbelly Corp owns and franchises hundreds of limited-service restaurants specializing in sandwiches and salads, shakes. The menu includes toasty sandwiches, signature salads, soups, chili, sides, desserts, and, in breakfast locations it serves breakfast sandwiches and steel-cut oatmeal. majority of its locations are company-owned and located in the United States, with Illinois and Texas housing far more locations than any other state. The company has franchise partners in a number of countries. Excluding the United States, its franchises are in the Middle East.